The prices and the coverage of effective direct-acting antivirals (DAAs) to treat hepatitis C vary across countries. South Korea expanded DAAs coverage through national health insurance.
Order of the Delhi High Court in the matter of Aditya Bhatia Vs Union of India & Others dated 15/04/2019 regarding permission to avail “Human Embryonic Stem Cell Therapy” being provided to the petitoner (Aditya Bhatia) by Nutech Mediworld.
Dr Harsh Vardhan, Union Minister of Health and Family Welfare released the National Digital Health Blueprint (NDHB) report in the public domain for inputs from various stakeholders.
Healthcare experts from India and the UK gathered for a first-of-its-kind conference in Birmingham to explore opportunities emerging after the Indian government's Ayushman Bharat initiative.
Union Health Secretary Preeti Sudan Sunday stressed on the partnerships with all stakeholders including doctors, paramedics, frontline health workers and community partners for achieving the goal o
NEW DELHI: Raising concerns over low penetration of health insurance, especially in the hinterland, and high ‘out of pocket’ expenditure on health, the insurance regulator has urged private insuran
The revolution in hepatitis C virus (HCV) treatment through the development of direct-acting antivirals (DAAs) has generated international interest in the global elimination of the disease as a public health threat. In 2017, this led WHO to establish elimination targets for 2030.